CONMED CNMD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $54.85M+16.6% | $47.06M-26.6% | $64.07M-41.9% | $110.2M-7.2% | $118.75M-10.3% | ||
| $17.08M-0.4% | $17.14M-0.8% | $17.28M+1.1% | $17.1M+1.8% | $16.79M+1.1% | ||
| $19.96M-29.5% | $28.32M-4.2% | $29.57M-4.9% | $31.11M-6.2% | $33.18M+29.8% | ||
| $7.72M+119% | $3.52M-62.1% | $9.29M+14.4% | $8.12M+5.8% | $7.68M-37.1% | ||
| $5.48M-3.0% | $5.65M+1.7% | $5.55M-2.9% | $5.72M-0.3% | $5.74M+0.6% | ||
| $2.74M+16.0% | $2.36M+130% | -$7.91M+16.9% | -$9.52M+47.9% | -$18.27M-1,229% | ||
| —— | —— | $22.44M-42.3% | $38.86M+14.1% | $34.06M+7.7% | ||
| —— | —— | —— | —— | -$4.97M-132% | ||
| $1.94M-87.0% | $14.91M— | —— | —— | —— | ||
| $24.95M+89.6% | $13.16M-20.5% | $16.55M+2.2% | $16.2M+29.1% | $12.55M-9.8% | ||
| -$6.61M-207% | $6.19M+213% | -$5.49M+1.4% | -$5.57M-156% | -$2.18M+48.8% | ||
| —— | -$558K-19.6% | -$466.75K-24.3% | -$375.5K-32.1% | -$284.25K-47.3% | ||
| $19.71M-14.1% | $22.95M+555% | $3.5M+114% | -$24.89M+21.6% | -$31.76M+24.9% | ||
| $142.63M-16.4% | $170.69M+1.8% | $167.69M+1.5% | $165.21M-7.9% | $179.38M+7.4% | ||
| $18.92M-4.5% | $19.81M+5.7% | $18.74M+10.4% | $16.97M+14.4% | $14.83M+13.3% | ||
| —— | —— | —— | —— | -$850K— | ||
| -$13.92M+33.6% | -$20.96M-17.2% | -$17.89M-11.0% | -$16.12M-15.3% | -$13.98M-6.8% | ||
| $18.57M-25.0% | $24.75M+0.1% | $24.73M+0.1% | $24.71M+0.1% | $24.68M+0.1% | ||
| —— | —— | —— | —— | —— | ||
| $709.43M+2.0% | $695.43M+5.6% | $658.43M+3.8% | $634.43M-4.3% | $663M-11.7% | ||
| $85.23M-14.6% | $99.82M+25.1% | $79.82M+45.6% | $54.82M+276% | $14.59M— | ||
| $1.46M+760% | $170K-54.2% | $371K-83.2% | $2.21M-4.0% | $2.3M-18.7% | ||
| -$129.98M+4.3% | -$135.82M+9.2% | -$149.52M-3.2% | -$144.83M+10.8% | -$162.38M-7.5% | ||
| $812K-66.8% | $2.45M+1,297% | $175K— | —— | —— | ||
| $1.1M-93.9% | $17.91M— | —— | —— | —— | ||
| —— | $25.42M-6.6% | $27.23M-6.2% | $29.04M-5.9% | $30.84M-5.5% | ||
| $5.48M-3.0% | $5.65M+1.7% | $5.55M-2.9% | $5.72M-0.3% | $5.74M+0.6% | ||
| $19.71M-14.1% | $22.95M+555% | $3.5M+114% | -$24.89M+21.6% | -$31.76M+24.9% | ||
| $17.08M-0.4% | $17.14M-0.8% | $17.28M+1.1% | $17.1M+1.8% | $16.79M+1.1% | ||
| —— | —— | —— | —— | —— | ||
| $1.94M-87.0% | $14.91M— | —— | —— | —— | ||
| $24.95M+89.6% | $13.16M-20.5% | $16.55M+2.2% | $16.2M+29.1% | $12.55M-9.8% | ||
| $57.78M+1.1% | $57.14M+1.7% | $56.16M+0.8% | $55.71M+0.8% | $55.28M0.0% | ||
| —— | —— | —— | —— | -$850K— | ||
| —— | —— | —— | —— | —— | ||
| $37.96M+12.4% | $33.76M+7.6% | $31.37M-0.5% | $31.54M-15.0% | $37.12M-34.7% | ||
| $1.46M+760% | $170K-54.2% | $371K-83.2% | $2.21M-4.0% | $2.3M-18.7% | ||
| $85.23M-14.6% | $99.82M+25.1% | $79.82M+45.6% | $54.82M+276% | $14.59M— | ||
| $123.71M-18.0% | $150.88M+1.3% | $148.96M+0.5% | $148.24M-9.9% | $164.55M+6.9% | ||
| $123.71M-18.0% | $150.88M+1.3% | $148.96M+0.5% | $148.24M-9.9% | $164.55M+6.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CONMED generate?
- CONMED (CNMD) generated $142.6M in operating cash flow over the trailing twelve months.
- What is CONMED's free cash flow?
- After $18.9M of capital expenditures, CONMED's free cash flow was $123.7M over the trailing twelve months, down 24.8% year over year.
- Where does CONMED's cash flow data come from?
- Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
